D. Yamauchi

发表

Comparison of immunoscintigraphy and computerized tomography in identifying colorectal cancer: individual lesion analysis.

J. Beatty, T. Odom-Maryon, L. Williams, 1991, Cancer research.

Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.

J M Esteban, L E Williams, A A Raubitschek, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.

Yi-Jen Chen, J. Bading, J. Wong, 2020, Cancer biotherapy & radiopharmaceuticals.

A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.

J. Wong, A. Wu, J. Shively, 2010, Cancer biotherapy & radiopharmaceuticals.

Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.

J. Doroshow, J. Wong, A. Wu, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer.

J. Beatty, R. Buras, L. Wagman, 1991, Archives of surgery.

Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

L. Leong, J. Wong, A. Wu, 2017, Cancer biotherapy & radiopharmaceuticals.

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

A. Nademanee, J. Bading, J. Wong, 2021, Blood advances.

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.

A. Nademanee, A. Krishnan, S. Forman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High Dose BEAM for Non-Hodgkin Lymphoma: The Role of Histology

A. Nademanee, A. Krishnan, S. Forman, 2017 .

Modification of a Motel-Type Room to Accommodate Patients Receiving Radioiodine Therapy: Reduction of Environmental Exposure

L. Williams, D. Yamauchi, C. Pickering, 2012, Health physics.

The Role of Positron Emission Tomography Scanning in Patients with Radioactive Iodine Scan-Negative, Recurrent Differentiated Thyroid Cancer

F. Kandeel, E. Maghami, J. Ellenhorn, 2007, The American surgeon.

relapsed non-Hodgkin lymphoma by autologous stem cell transplantation in patients with poor-risk or combination with high-dose etoposide and cyclophosphamide followed A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in

David D. Smith, A. Nademanee, A. Krishnan, 2013 .

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.

David D. Smith, A. Nademanee, A. Krishnan, 2005, Blood.

Impact of radiolabeled antibody imaging on management of colon cancer.

R. Paxton, J. Beatty, B. Beatty, 1989, American journal of surgery.

Presurgical imaging with indium-labeled anti-carcinoembryonic antigen for colon cancer staging.

L. R. Hill, R. Paxton, J. Beatty, 1990, Cancer research.

Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.

A. Nademanee, A. Krishnan, S. Forman, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.

L. Leong, J. Wong, A. Wu, 2006, Cancer biotherapy & radiopharmaceuticals.

First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.

Yi-Jen Chen, J. Wong, A. Wu, 2022, Cancer biotherapy & radiopharmaceuticals.

High-Dose Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Non-Hodgkin's Lymphoma (NHL)

David D. Smith, A. Nademanee, A. Krishnan, 2017 .

Non-Hodgkins Lymphoma (NHL) by Autologous Stem Cell Transplant in Patients with Poor-Risk or Relapsed Combination with High-Dose Etoposide and Cyclophosphamide Followed A Phase I/II Trial of High-Dose Yttrium 90 ibritumomab tiuxetan in

David D. Smith, A. Nademanee, A. Krishnan, 2013 .

Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.

J. Niland, A. Krishnan, R. Bhatia, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.

J. Doroshow, J. Wong, A. Wu, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.

J M Esteban, L E Williams, M. Neumaier, 1995, Cancer research.

Computed tomography in endobronchial neoplasms.

O J Balchum, P. Colletti, O. Balchum, 1990, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.

Paul J Yazaki, Anna M Wu, James H Doroshow, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

A Phase I Trial of 90 Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

J. Doroshow, J. Wong, A. Wu, 2003 .

Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer

Paul J Yazaki, Anna M Wu, J. Wong, 2004, Clinical Cancer Research.

Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.

J M Esteban, L E Williams, A A Raubitschek, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The two types of correction of absorbed dose estimates for internal emitters

An Liu, J. Wong, L. Williams, 2002, Cancer.

Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab.

A. Krishnan, F. Pichiorri, R. Rockne, 2020, Blood advances.